New combo tested to fight advanced lung cancer after first treatment fails
Disease control
Completed
This study tested whether adding a new drug called Imprime PGG to an existing immunotherapy (pembrolizumab) could help control advanced lung cancer that had worsened after initial chemotherapy. It involved 35 adults with metastatic non-small cell lung cancer. The research first a…
Phase: PHASE1, PHASE2 • Sponsor: Lawrence Feldman, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC